OptiSeq™ NGS Panels

About DiaCarta

DiaCarta is a commercial-stage diagnostics company with a focus on oncology and infectious diseases, utilizing its proprietary XNA and isobDNA™ technologies to enhance mutation detection sensitivity. Its product portfolio includes liquid biopsy tests for cancer therapy monitoring (RadTox™), colorectal cancer screening (ColoScape™), and bladder cancer detection (Oncuria®), alongside FDA-EUA infectious disease tests. The company has achieved significant commercial milestones, including Medicare coverage for RadTox™ and a statewide contract in Florida, supported by a CAP-accredited CLIA lab and global operations.

Therapeutic Areas